Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany (Q39983387)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

16 September 2017

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany (English)

1 reference

Europe PubMed Central

16 September 2017

0 references

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

Mark van der Linden

2

1 reference

Europe PubMed Central

16 September 2017

Rüdiger von Kries

4

object named as

Rüdiger von Kries

1 reference

Europe PubMed Central

16 September 2017

author name string

Simon Rückinger

1

1 reference

Europe PubMed Central

16 September 2017

Ralf René Reinert

3

1 reference

Europe PubMed Central

16 September 2017

Florian Burckhardt

5

1 reference

Europe PubMed Central

16 September 2017

Anette Siedler

6

1 reference

Europe PubMed Central

16 September 2017

language of work or name

0 references

publication date

9 May 2009

1 reference

Europe PubMed Central

16 September 2017

1 reference

Europe PubMed Central

16 September 2017

27

1 reference

Europe PubMed Central

16 September 2017

31

1 reference

Europe PubMed Central

16 September 2017

4136-4141

1 reference

Europe PubMed Central

16 September 2017

The pneumococcal problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Meningitis in infancy in England and Wales: follow up at age 5 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Invasive pneumococcal disease in an Alaska native population, 1980 through 1986.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Childhood invasive pneumococcal disease in Germany between 1997 and 2003: Variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Ueber die Agglutination der Pneumokokken und über die Theorieen der Agglutination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Blood culture sampling rates at a German pediatric university hospital and incidence of invasive pneumococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999-2000 and the in vitro efficacy of telithromycin and comparators

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Prevenar vaccination: review of the global data, 2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.057

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.04.057

1 reference

Europe PubMed Central

16 September 2017

1 reference

Europe PubMed Central

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39983387&oldid=1881712243"